Researchers from the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide, spearheaded by Dr. Courtney Cross, have unveiled an exciting correlation between fiber supplementation and a reduction in brain inflammation—specifically, inflammation ensuing from chemotherapy.
Their findings, elucidated in the journal Brain, Behavior, and Immunity, might open new therapeutic avenues for mitigating the physical and psychological ramifications of chemotherapy-induced brain inflammation.
Linking Fiber, the Gut Microbiome, and Brain Inflammation
The team’s exploration into fiber’s possible neuroprotective effects uncovered that it prompted beneficial shifts in the gut microbiome, which could subsequently dampen brain inflammation post-chemotherapy.
Their pre-clinical models illustrated a compelling 50% reduction in inflammation within the brain area pivotal for memory.
The mechanism underpinning this involves dietary fiber modulating the microbiome to amplify the presence of beneficial microbes that generate anti-inflammatory metabolites known as short-chain fatty acids (SCFAs).
These SCFAs can permeate the bloodstream and attenuate inflammation throughout the body, inclusive of the brain.
Addressing a Spectrum of Neuropsychological Challenges
This potential mitigation of brain inflammation is especially noteworthy given its association with a plethora of neuropsychological challenges, such as cognitive impairment, depression, and anxiety, which frequently emerge as debilitating side-effects during cancer treatments.
The fear of cancer returning is another psychological hurdle where brain inflammation may play a role.
This focus on alleviating the non-physical aftermath of cancer treatment aligns with Dr. Cross’s and her team’s dedication to enhancing the quality of life among those navigating the cancer journey.
Chronic chemotherapy, despite being a preventative measure against cancer’s recurrence, invariably impinges upon patients’ lives due to its side effects.
Dr. Cross articulates a palpable optimism, observing that the simplicity, cost-effectiveness, and ease of implementing fiber supplementation render it a particularly appealing intervention.
With an ability to potentially assuage a host of neuropsychological symptoms with a single approach, the promise is indeed considerable.
The Road Ahead: Clinical Trials and Beyond
The research team’s sights are now set on initiating clinical trials to validate whether the ameliorative impacts of increased dietary fiber intake observed in their pre-clinical models hold true in human subjects as well.
Should these trials affirm the initial findings, fiber supplementation could emerge as a simple yet potent strategy to mitigate the multifaceted neuropsychological challenges faced by individuals undergoing chemotherapy.
The simplicity of such an intervention holds promise for easily integrating it into the management and supportive care plans for patients grappling with the rigors of long-term cancer treatment.
For more information about health, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing berry that can prevent cancer, diabetes, and obesity.
The research findings can be found in Brain, Behavior, and Immunity.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.